Cost-effectiveness of breast cancer screening policies in Mexico

Generate cost-effectiveness information to allow policy makers optimize breast cancer (BC) policy in Mexico. We constructed a Markov model that incorporates four interrelated processes of the disease: the natural history; detection using mammography; treatment; and other competing-causes mortality,...

Full description

Saved in:
Bibliographic Details
Published inSalud pública de México Vol. 51 Suppl 2; pp. s296 - s304
Main Authors Valencia-Mendoza, Atanacio, Sánchez-González, Gilberto, Bautista-Arredondo, Sergio, Torres-Mejía, Gabriela, Bertozzi, Stefano M
Format Journal Article
LanguageSpanish
Published Mexico 2009
Subjects
Adult
Aged
Aged, 80 and over
Breast Neoplasms - diagnosis
Breast Neoplasms - economics
Breast Neoplasms - epidemiology
Cost-Benefit Analysis
Female
Health Policy
Humans
Markov Chains
Mass Screening - economics
Mexico
Middle Aged
Mexico
Online AccessGet full text

Cover

More Information
Summary:Generate cost-effectiveness information to allow policy makers optimize breast cancer (BC) policy in Mexico. We constructed a Markov model that incorporates four interrelated processes of the disease: the natural history; detection using mammography; treatment; and other competing-causes mortality, according to which 13 different strategies were modeled. Strategies (starting age, % of coverage, frequency in years)= (48, 25, 2), (40, 50, 2) and (40, 50, 1) constituted the optimal method for expanding the BC program, yielding 75.3, 116.4 and 171.1 thousand pesos per life-year saved, respectively. The strategies included in the optimal method for expanding the program produce a cost per life-year saved of less than two times the GNP per capita and hence are cost-effective according to WHO Commission on Macroeconomics and Health criteria.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1606-7916
DOI:10.1590/S0036-36342009000800020